Patient satisfaction at 24 months after treatment for localized prostate cancer

The ability to “manage” patients’ satisfaction with their care in the treatment of localized prostate cancer is challenging — for patients, for caregivers, for physicians, and for health systems. … READ MORE …

PREDICT Prostate: a new, sophisticated, prostate cancer prognostic tool

A new paper just published in PLOS Medicine describes the development of a new online tool called PREDICT Prostate. … READ MORE …

America est omnis divisa in tria genera hominum

For readers who are less than familiar with the books properly known as Caesaris Comentarii de Bello Gallico (or more simply, Caesar’s Gallic Wars), written between about 58 and  44 BCE, please understand that almost all European schoolchildren of a certain generation used to know that the first of these eight books began, “Gallia est omnis divisa in tres partes” or “All of Gaul is divided into three parts”. … READ MORE …

Estimation of life expectancy for newly diagnosed men with prostate cancer

A critical question for every patient newly diagnosed with prostate cancer is going to be, “How long am I going to live”? That question may be particularly important if a second and associated question is, “How long am I going to live if I just monitor my cancer on active surveillance or watchful waiting?” … READ MORE …

Decision aids, PSA-based screening, and male decision-making

According to a newly published study in JAMA Internal Medicine, web-based and print-based decision aids do help men to resolve their own internal conflicts about whether or not to get PSA tests for risk of prostate cancer … READ MORE …

A web-based system for assessment of functional recovery post-RP

At the beginning of 2010, The “New” Prostate Cancer InfoLink collaborated with a research team at Memorial Sloan-Kettering Cancer Center (MSKCC) to get patient input on the format of web-based feedback pages designed to inform patients about their functional recovery over time after radical prostatectomy (RP) for localized prostate cancer. … READ MORE …

The CaP Calculator: a new, sophisticated, decision-support tool

Long, long ago (in September 2008), we initially reported on the existence of a prostate cancer decision support tool (then in very early-stage development) known as the CaP Calculator. … READ MORE …